Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Seminal bacteria can lower sperm quality in subfertile men.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

The technique effectively promotes hair growth in young men with androgenetic alopecia.

Dutasteride for hair loss might increase the risk of a rare stroke type.

New hair loss treatments show promise, but more research is needed to confirm their effectiveness.

Consider benefits and risks of new alopecia treatments for safety.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Dutasteride may help reduce brain inflammation and improve cognition.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Scalp needle mesotherapy can effectively treat hair loss and improve hair growth.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.